Connect with us

Hi, what are you looking for?

Big States NewsBig States News

Investing

Locksley Resources (ASX:LKY,OTQB:LKYRF,FSE: X5L) has been featured by The Sydney Morning Herald after achieving a major metallurgical breakthrough at its Desert antimony mine in...

Investing

JZR Gold (TSXV:JZR) is advancing its Vila Nova gold project in Amapá, Brazil, to deliver sustainable shareholder value. The company is commissioning its Vila...

Investing

Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) ( ‘ Skyharbour ‘ or the ‘ Company ‘) is pleased to...

Investing

Steadright Critical Minerals Inc. (CSE: SCM) (“Steadright” or the “Company”) is pleased to announce that it has entered into an MOU to purchase two...

World News

World News

“And there’s very few states that benefit like you do from fracking. I mean, you have 500,000 jobs.” — Former president Donald Trump, remarks...

World News

DULUTH, Ga. — Former Fox News host Tucker Carlson warmed up the crowd at Donald Trump’s rally here Wednesday night with a dark metaphor,...

World News

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

World News

A former deputy Palm Beach County sheriff who fled to Moscow and became one of the Kremlin’s most prolific propagandists is working directly with...

Investing News

Investing

Lynette Zang, CEO of Zang Enterprises, shares her thoughts on what the gold and silver price surge says about the world today, emphasizing that...

Investing

Haytham Hodaly of Wheaton Precious Metals (TSX:WPM,NYSE:WPM) discusses what’s driving gold and silver’s record-setting price moves. He also weighs in on the company’s bull...

Investing

Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to...

Investing

Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to...

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.